ID: ALA2414975

Max Phase: Preclinical

Molecular Formula: C13H10N2O

Molecular Weight: 210.24

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  c1ccc2c3c([nH]c2c1)-c1oncc1CC3

Standard InChI:  InChI=1S/C13H10N2O/c1-2-4-11-9(3-1)10-6-5-8-7-14-16-13(8)12(10)15-11/h1-4,7,15H,5-6H2

Standard InChI Key:  ZVLKOIMSNOWANI-UHFFFAOYSA-N

Associated Targets(Human)

MAPK10 Tchem Mitogen-activated protein kinase 10/Receptor-interacting serine/threonine-protein kinase 1 (33 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 210.24Molecular Weight (Monoisotopic): 210.0793AlogP: 2.92#Rotatable Bonds: 0
Polar Surface Area: 41.82Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 0.20CX LogP: 2.49CX LogD: 2.49
Aromatic Rings: 3Heavy Atoms: 16QED Weighted: 0.62Np Likeness Score: -0.20

References

1. Wu Z, Li Y, Cai Y, Yuan J, Yuan C..  (2013)  A novel necroptosis inhibitor-necrostatin-21 and its SAR study.,  23  (17): [PMID:23886688] [10.1016/j.bmcl.2013.06.073]

Source